Cardiology-specific ASCs are faced with new challenges as payers update policies amid these high-acuity procedures' migration to the outpatient setting.
Author: Patsy Newitt
Cardiology is one of the biggest opportunities for ASC growth as procedures are increasingly approved for the outpatient setting.
ASCs are a component of St. Louis-based Ascension plans for growth amid a $3 billion operating loss in fiscal 2023.
Optum, the country's largest employer of physicians and parent company of ASC chain SCA Health, has revealed plans to shutter several clinics so far in 2024.
A class action lawsuit has been filed against Portland-based Providence Health and Oregon Anesthesiology Group after one anesthesiologists alleged negligence led to potential hepatitis and HIV exposures, NBC affiliate KGW reported July 28.
Advertisement
ASC leaders and hospitals alike are facing major obstacles to profitability as operational costs soar and Medicare and private payer reimbursement rates sink.
Benita Tapia, RN, administrator and director of nursing at Beverly Hills, Calif.-based 90210 Surgery Center, joined Becker's to discuss what's missing in ASC conversations with payers.
From ASCs' cost-savings potential to patient outcomes, 13 leaders joined Becker's to discuss the gaps in communication between ASCs and payers.
ASCs in many markets are struggling for leverage with payers, up against massive hospital systems and sparse cost information from the insurance companies.
Walmart and other retail companies' efforts to use a big box formula in healthcare have not gone as planned, The Wall Street Journal reported July 5.